1 study found for:    NCT00932893
Show Display Options
RSS Create an RSS feed from your search for:
NCT00932893
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting
Has Results
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: PF-02341066;   Drug: Pemetrexed;   Drug: Docetaxel

Indicates status has not been verified in more than two years